EUVIMEDEUVIMED entdecken
Crossref

Predictive performance of the sequential organ failure assessment score for in‐hospital mortality in patients with end‐stage kidney disease in intensive care units: A multicenter registry in Japan

Hiroki Shimada iD, Yoshinori Matsuoka, Chisato Miyakoshi, Jiro Ito, Ryutaro Seo, Koichi Ariyoshi, Yosuke Yamamoto, Hiroyuki Mima

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Hiroki Shimada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Critical Care, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Organ Dysfunction Scores. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is limited evidence regarding whether the performance of the Sequential Organ Failure Assessment (SOFA) score differs between patients with and without end‐stage kidney disease (ESKD) in intensive care units (ICUs).

Methods

We used a multicenter registry (Japanese Intensive care Patient Database) to enroll adult ICU patients between April 2018 and March 2021. We recalibrated the SOFA score using a logistic regression model and evaluated its predictive ability in both ESKD and non‐ESKD groups. The primary outcome was in‐hospital mortality.

Results

128 134 patients were enrolled. The AUROC of the SOFA score was lower in the ESKD group than in the non‐ESKD group [0.789 (95% CI, 0.774–0.804) vs. 0.846 (95% CI, 0.841–0.850)]. The calibration plot revealed good performance in both groups. However, it overestimated in‐hospital mortality in ESKD groups.

Conclusion

The SOFA score demonstrated good predictive ability in patients with and without ESKD, but it overestimated the in‐hospital mortality in ESKD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Failure, ChronicOrgan Dysfunction ScoresAdultHumansHospital MortalityIntensive Care UnitsJapanPrognosisRegistriesRetrospective StudiesROC CurveMulticenter Studies as Topic

Stichwörter der Autor:innen

clinical prediction modelend-stage kidney diseasein-hospital mortalityintensive care unitsequential organ failure assessment score

Autor:innen und Institutionen

  • Department of Anesthesia and Critical Care, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Department of Emergency Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.

ORCID-Profile: Hiroki Shimada

Zitieren

APA

Shimada, H., Matsuoka, Y., Miyakoshi, C., Ito, J., Seo, R., Ariyoshi, K., Yamamoto, Y., & Mima, H. (2024). Predictive performance of the sequential organ failure assessment score for in‐hospital mortality in patients with end‐stage kidney disease in intensive care units: A multicenter registry in Japan. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14089

Vancouver

Shimada H, Matsuoka Y, Miyakoshi C, Ito J, Seo R, Ariyoshi K, et al. Predictive performance of the sequential organ failure assessment score for in‐hospital mortality in patients with end‐stage kidney disease in intensive care units: A multicenter registry in Japan. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14089

BibTeX
@article{Shimada2024,
  author = {Shimada, Hiroki and Matsuoka, Yoshinori and Miyakoshi, Chisato and Ito, Jiro and Seo, Ryutaro and Ariyoshi, Koichi and Yamamoto, Yosuke and Mima, Hiroyuki},
  title = {Predictive performance of the sequential organ failure assessment score for in‐hospital mortality in patients with end‐stage kidney disease in intensive care units: A multicenter registry in Japan},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14089}
}
Kostenlos starten →